THB 375. 61 million or equal to EPS of THB 0. 30 per share, or 14. 02% down from 3Q2018. For capital structure of the Group, as at September 30, 2019, the consolidated debt to equity ratio was 0.40 time
share (Baht/Share) 0.21 0.22 (0.01) (5.1) 0.28 0.26 0.02 7.8 In the year 2019, The total revenue from the Company and its subsidiary was Baht 1,648 million which increased from the previous year Baht 37
share (Baht/Share) 0.21 0.22 (0.01) (5.1) 0.28 0.26 0.02 7.8 In the year 2019, The total revenue from the Company and its subsidiary was Baht 1,648 million which increased from the previous year Baht 37
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
expenses -0.72 -5.45 -4.73 -87% Net income for period 0.01 28.10 -28.09 -100% Earnings per share (THB) 0.00 0.09 -0.09 -100% H1 2019 H1 2018 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and
shareholders and the share repurchase of the subsidiary. The appropriate of capital structure The debt to equity ratio as at 30 June 2018 was 2.4: 1, increased from the debt-to-equity ratio as at 31 December
at 31 December 2017, which was Baht 2,720 million. The change was due to the net profit for the period, the dividend payment to the shareholders and the share repurchase of the subsidiary. The
before share of profit from associates and NCI 824 940 -12.3 1,487 4,755 -68.7 Share of profit from investments in associates, net - - - - 173 -100.0 NCI (2) (3) 33.3 (5) (15) 66.7 Profit attributable to
12.47 9.71 1.89 NP 411.61 9.87 392.03 9.52 19.58 4.99 EPS (Baht per Share) * 0.43 0.39 0.04 10.26 Weighted Average Number of Ordinary Shares (Million Shares) * 947.96 997.41 (49.45) (4.96) Return on
/1 1,408.0 1,586.1 178.1 12.6% Share of Profit from Investments in Associates and JVs 220.5 563.4 342.9 155.6% Total Cost 621.7 691.7 70.0 11.3% Gross Profit 686.7 558.2 (128.5) (18.7%) Net Profit 42.6